Sharp Shalini Insider Trades

Insider Trading History

Track insider trading activity for Sharp Shalini. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Septerna
Septerna SEPN
Director
Holding Value $518k 15,000 shares
Last Trade
Jun 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$560k 15,000 shares
$37.34
$34.54
Organon
Organon OGN
Director
Holding Value $1.1M 81,495 shares
Last Trade
Jun 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$240k 17,857 shares
$13.44
$13.50
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $442k 2,567 shares
Last Trade
May 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 2,567 shares
$155.83
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $0 0 shares
Last Trade
May 21, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$258k 1,659 shares
$155.50
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $703k 4,088 shares
Last Trade
May 21, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$258k 1,659 shares
$155.50
$172.04
Septerna
Septerna SEPN
Director
Holding Value $574k 16,623 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$170k 16,623 shares
$10.24
$34.54
Organon
Organon OGN
Director
Holding Value $851k 63,054 shares
Last Trade
Jun 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$240k 23,904 shares
$10.04
$13.50
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $0 0 shares
Last Trade
May 22, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$171k 1,435 shares
$119.12
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $418k 2,429 shares
Last Trade
May 22, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$171k 1,435 shares
$119.12
$172.04
BeiGene
BeiGene BGNE
Director
Holding Value $4.2M 22,750 shares
Last Trade
May 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.2M 22,750 shares
$184.71
$184.71
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $569k 3,305 shares
Last Trade
May 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$398k 3,305 shares
$120.56
$172.04
BeiGene
BeiGene BGNE
Director
Holding Value $3.18M 17,238 shares
Last Trade
Sep 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.87M 17,238 shares
$224.51
$184.71
Organon
Organon OGN
Director
Holding Value $497k 36,783 shares
Last Trade
Jun 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$200k 9,638 shares
$20.75
$13.50
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $513k 2,982 shares
Last Trade
May 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$416k 2,982 shares
$139.43
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $0 0 shares
Last Trade
May 17, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$299k 2,100 shares
$142.29
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $361k 2,100 shares
Last Trade
May 17, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$299k 2,100 shares
$142.29
$172.04
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $171k 994 shares
Last Trade
May 17, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$157k 1,106 shares
$141.90
$172.04
Mirati Therapeutics
Mirati Therapeutics MRTX
Director
Holding Value $708k 12,060 shares
Last Trade
Jan 23, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$686k 11,682 shares
$58.70
$58.70
Mirati Therapeutics
Mirati Therapeutics MRTX
Director
Holding Value $952k 16,222 shares
Last Trade
Dec 29, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 6,808 shares
$58.75
$58.70
Organon
Organon OGN
Director
Holding Value $346k 25,594 shares
Last Trade
Jun 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$200k 10,086 shares
$19.83
$13.50

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up